Quick Answer
Aldeyra Therapeutics, Inc. reported Total Assets of $72.06 million for fiscal year 2025.
Aldeyra Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $72.06M | -31.1% |
| 2024 | $104.61M | -29.5% |
| 2023 | $148.33M | -18.2% |
| 2022 | $181.29M | -22.2% |
| 2021 | $233.14M | +179.7% |
| 2020 | $83.35M | +10.4% |
| 2019 | $75.52M | -20.6% |
| 2018 | $95.09M | +115.3% |
| 2017 | $44.17M | +75.4% |
| 2016 | $25.19M | -10.7% |
| 2015 | $28.20M | +221.0% |
| 2014 | $8.79M | +134.7% |
| 2013 | $3.74M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $77.80M | -33.7% | -8.4% |
| June 30, 2025 | $84.96M | -32.6% | -8.8% |
| March 31, 2025 | $93.20M | -34.0% | -10.9% |
| December 31, 2024 | $104.61M | -29.5% | -10.8% |
| September 30, 2024 | $117.32M | -20.3% | -6.9% |
| June 30, 2024 | $126.04M | -19.0% | -10.8% |
| March 31, 2024 | $141.30M | -16.0% | -4.7% |
| December 31, 2023 | $148.33M | -18.2% | +0.7% |
- Aldeyra Therapeutics, Inc. showed a decrease of -31.1% in Total Assets compared to the prior fiscal year.
- Over the 2013–2025 period, Aldeyra Therapeutics, Inc.’s total assets has grown by 1825.1% (from $3.74 million to $72.06 million).
- The most recent figure is from Aldeyra Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: